341 related articles for article (PubMed ID: 25128518)
1. A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study.
Markusse IM; Dirven L; van den Broek M; Bijkerk C; Han KH; Ronday HK; Bolce R; Sasso EH; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
J Rheumatol; 2014 Nov; 41(11):2114-9. PubMed ID: 25128518
[TBL] [Abstract][Full Text] [Related]
2. Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.
Li W; Sasso EH; van der Helm-van Mil AH; Huizinga TW
Rheumatology (Oxford); 2016 Feb; 55(2):357-66. PubMed ID: 26385370
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
Brahe CH; Østergaard M; Johansen JS; Defranoux N; Wang X; Bolce R; Sasso EH; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll C; Jørgensen A; Krintel SB; Raun J; Hetland ML
Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression.
van der Helm-van Mil AH; Knevel R; Cavet G; Huizinga TW; Haney DJ
Rheumatology (Oxford); 2013 May; 52(5):839-46. PubMed ID: 23287359
[TBL] [Abstract][Full Text] [Related]
5. A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes.
Bouman CAM; van der Maas A; van Herwaarden N; Sasso EH; van den Hoogen FHJ; den Broeder AA
Rheumatology (Oxford); 2017 Jun; 56(6):973-980. PubMed ID: 28339738
[TBL] [Abstract][Full Text] [Related]
6. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies.
Roodenrijs NMT; de Hair MJH; Wheater G; Elshahaly M; Tekstra J; Teng YKO; Lafeber FPJG; Hwang CC; Liu X; Sasso EH; van Laar JM
Arthritis Res Ther; 2018 Nov; 20(1):256. PubMed ID: 30458871
[TBL] [Abstract][Full Text] [Related]
7. Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.
Rech J; Hueber AJ; Finzel S; Englbrecht M; Haschka J; Manger B; Kleyer A; Reiser M; Cobra JF; Figueiredo C; Tony HP; Kleinert S; Wendler J; Schuch F; Ronneberger M; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Lorenz HM; Nuesslein H; Alten R; Henes J; Krueger K; Schett G
Ann Rheum Dis; 2016 Sep; 75(9):1637-44. PubMed ID: 26483255
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF
Ann Rheum Dis; 2015 Jun; 74(6):1102-9. PubMed ID: 24812287
[TBL] [Abstract][Full Text] [Related]
9. Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice.
Hirata S; Li W; Kubo S; Fukuyo S; Mizuno Y; Hanami K; Sawamukai N; Yamaoka K; Saito K; Defranoux NA; Tanaka Y
Mod Rheumatol; 2016 Nov; 26(6):850-856. PubMed ID: 26873570
[TBL] [Abstract][Full Text] [Related]
10. Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies.
Curtis JR; Brahe CH; Østergaard M; Lund Hetland M; Hambardzumyan K; Saevarsdottir S; Wang X; Flake Ii DD; Sasso EH; Huizinga TW
Curr Med Res Opin; 2019 Sep; 35(9):1483-1493. PubMed ID: 30777458
[No Abstract] [Full Text] [Related]
11. Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.
Curtis JR; van der Helm-van Mil AH; Knevel R; Huizinga TW; Haney DJ; Shen Y; Ramanujan S; Cavet G; Centola M; Hesterberg LK; Chernoff D; Ford K; Shadick NA; Hamburger M; Fleischmann R; Keystone E; Weinblatt ME
Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1794-803. PubMed ID: 22736476
[TBL] [Abstract][Full Text] [Related]
12. Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis.
Meznerics FA; Kemény LV; Gunther E; Bakó E; Dembrovszky F; Szabó B; Ascsillán A; Lutz E; Csupor D; Hegyi P; Bánvölgyi A; Nagy G
Rheumatology (Oxford); 2023 Jun; 62(6):2048-2059. PubMed ID: 36575983
[TBL] [Abstract][Full Text] [Related]
13. Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies.
Curtis JR; Weinblatt ME; Shadick NA; Brahe CH; Østergaard M; Hetland ML; Saevarsdottir S; Horton M; Mabey B; Flake DD; Ben-Shachar R; Sasso EH; Huizinga TW
Arthritis Res Ther; 2021 Jan; 23(1):1. PubMed ID: 33397438
[TBL] [Abstract][Full Text] [Related]
14. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
Reneses S; González-Escribano MF; Fernández-Suárez A; Pestana L; Davila B; Wichmann I; García A
J Rheumatol; 2009 Jun; 36(6):1143-9. PubMed ID: 19411391
[TBL] [Abstract][Full Text] [Related]
15. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity.
Foltz V; Gandjbakhch F; Etchepare F; Rosenberg C; Tanguy ML; Rozenberg S; Bourgeois P; Fautrel B
Arthritis Rheum; 2012 Jan; 64(1):67-76. PubMed ID: 21904998
[TBL] [Abstract][Full Text] [Related]
16. Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.
Hambardzumyan K; Bolce RJ; Saevarsdottir S; Forslind K; Wallman JK; Cruickshank SE; Sasso EH; Chernoff D; van Vollenhoven RF
RMD Open; 2016; 2(1):e000197. PubMed ID: 26958364
[TBL] [Abstract][Full Text] [Related]
17. Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia.
Lee YC; Hackett J; Frits M; Iannaccone CK; Shadick NA; Weinblatt ME; Segurado OG; Sasso EH
Rheumatology (Oxford); 2016 Apr; 55(4):640-8. PubMed ID: 26608972
[TBL] [Abstract][Full Text] [Related]
18. Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study.
Bakker MF; Cavet G; Jacobs JW; Bijlsma JW; Haney DJ; Shen Y; Hesterberg LK; Smith DR; Centola M; van Roon JA; Lafeber FP; Welsing PM
Ann Rheum Dis; 2012 Oct; 71(10):1692-7. PubMed ID: 22596166
[TBL] [Abstract][Full Text] [Related]
19. Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.
Reiss WG; Devenport JN; Low JM; Wu G; Sasso EH
Rheumatol Int; 2016 Feb; 36(2):295-300. PubMed ID: 26026604
[TBL] [Abstract][Full Text] [Related]
20. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.
Nyhäll-Wåhlin BM; Turesson C; Jacobsson LT; Nilsson JÅ; Forslind K; Albertsson K; Rönnelid J; Petersson IF
Scand J Rheumatol; 2011 Mar; 40(2):81-7. PubMed ID: 20919947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
